Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSS1900065	注射用重组人凝血因子IX -Fc融合蛋白	eftrenonacog alfa	Lyophilized	Biological Products	Import Drug Application	2019-11-27	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2019-12-14	view
JXSS1900064	注射用重组人凝血因子IX -Fc融合蛋白	eftrenonacog alfa	Lyophilized	Biological Products	Import Drug Application	2019-11-27	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2019-12-14	view
JXSS1900063	注射用重组人凝血因子IX -Fc融合蛋白	eftrenonacog alfa	Lyophilized	Biological Products	Import Drug Application	2019-11-27	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2019-12-14	view
JXSS1900062	注射用重组人凝血因子IX -Fc融合蛋白	eftrenonacog alfa	Lyophilized	Biological Products	Import Drug Application	2019-11-27	赛诺菲（中国）投资有限公司	Sanofi (China) Investment Co Ltd	In Review	2019-12-14	view